• Japanese
  • Korean
  • Chinese
Cover Image

Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012

Abstract

Summary

GlobalData's clinical trial report, "Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2012" provides data on the Irritable Bowel Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Irritable Bowel Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Irritable Bowel Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Irritable Bowel Syndrome Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Irritable Bowel Syndrome , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Irritable Bowel Syndrome
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Irritable Bowel Syndrome
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Irritable Bowel Syndrome Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
    • GlaxoSmithKline plc
    • Clinical Trial Overview of GlaxoSmithKline plc
    • Astellas Pharma Inc.
    • Clinical Trial Overview of Astellas Pharma Inc.
    • Salix Pharmaceuticals, Inc.
    • Clinical Trial Overview of Salix Pharmaceuticals, Inc.
    • Almirall, S.A.
    • Clinical Trial Overview of Almirall, S.A.
    • Sucampo Pharmaceuticals, Inc.
    • Clinical Trial Overview of Sucampo Pharmaceuticals, Inc.
    • Lexicon Pharmaceuticals, Inc.
    • Clinical Trial Overview of Lexicon Pharmaceuticals, Inc.
    • Ironwood Pharmaceuticals, Inc.
    • Clinical Trial Overview of Ironwood Pharmaceuticals, Inc.
    • Yakult Honsha Co., Ltd.
    • Clinical Trial Overview of Yakult Honsha Co., Ltd.
    • AGI Therapeutics plc
    • Clinical Trial Overview of AGI Therapeutics plc
    • Tioga Pharmaceuticals, Inc.
    • Clinical Trial Overview of Tioga Pharmaceuticals, Inc.
    • Dynogen Pharmaceuticals, Inc.
    • Clinical Trial Overview of Dynogen Pharmaceuticals, Inc.
    • SOFAR SPA
    • Clinical Trial Overview of SOFAR SPA
    • Danone Research B.V.
    • Clinical Trial Overview of Danone Research B.V.
    • Novartis AG
    • Clinical Trial Overview of Novartis AG
    • Forest Laboratories, Inc.
    • Clinical Trial Overview of Forest Laboratories, Inc.
    • Ono Pharmaceutical Co., Ltd.
    • Clinical Trial Overview of Ono Pharmaceutical Co., Ltd.
    • Alizyme plc
    • Clinical Trial Overview of Alizyme plc
    • Laboratoires Mayoly Spindler
    • Clinical Trial Overview of Laboratoires Mayoly Spindler
    • Trine Pharmaceuticals, Inc.
    • Clinical Trial Overview of Trine Pharmaceuticals, Inc.
    • Ardeypharm GmbH
    • Clinical Trial Overview of Ardeypharm GmbH
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
    • Mayo Clinic
    • Clinical Trial Overview of Mayo Clinic
    • The University of North Carolina
    • Clinical Trial Overview of The University of North Carolina
    • Maastricht University Medical Center
    • Clinical Trial Overview of Maastricht University Medical Center
    • Baylor College of Medicine
    • Clinical Trial Overview of Baylor College of Medicine
    • Sahlgrenska University Hospital
    • Clinical Trial Overview of Sahlgrenska University Hospital
    • Chinese University of Hong Kong
    • Clinical Trial Overview of Chinese University of Hong Kong
    • Karolinska Institutet
    • Clinical Trial Overview of Karolinska Institutet
    • Academic Medical Centre
    • Clinical Trial Overview of Academic Medical Centre
    • Cedars-Sinai Medical Center
    • Clinical Trial Overview of Cedars-Sinai Medical Center
    • University of Florida
    • Clinical Trial Overview of University of Florida
    • Medical College of Wisconsin
    • Clinical Trial Overview of Medical College of Wisconsin
    • National University Hospital
    • Clinical Trial Overview of National University Hospital
    • Penn State University
    • Clinical Trial Overview of Penn State University
    • UMC Utrecht
    • Clinical Trial Overview of UMC Utrecht
    • University of Missouri
    • Clinical Trial Overview of University of Missouri
    • University of Washington
    • Clinical Trial Overview of University of Washington
    • McGill University Health Center
    • Clinical Trial Overview of McGill University Health Center
    • University of California, Los Angeles
    • Clinical Trial Overview of University of California, Los Angeles
    • University of Southern Denmark
    • Clinical Trial Overview of University of Southern Denmark
    • Meir Medical Center
    • Clinical Trial Overview of Meir Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, BRIC Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, G7 Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, E7 Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Suspended Clinical Trials, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Terminated Clinical Trials, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals, Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Almirall, S.A., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Lexicon Pharmaceuticals, Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ironwood Pharmaceuticals, Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Yakult Honsha Co., Ltd., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by AGI Therapeutics plc, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Tioga Pharmaceuticals, Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Dynogen Pharmaceuticals, Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by SOFAR SPA, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Danone Research B.V., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Alizyme plc, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Mayoly Spindler, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Trine Pharmaceuticals, Inc., 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ardeypharm GmbH, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of North Carolina, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Hospital, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern Denmark, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Meir Medical Center, 2012*

List of Figures

  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, BRIC Countries (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, G7 Countries (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, E7 Countries (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • GlobalData Methodology
Show More
Pricing
Get Notified
Email me when related reports are published